| Similar Articles |
|---|
 |
The Motley Fool
January 21, 2010
Dan Caplinger |
Doing This Will Just Drive You Crazy Short-term stock movements are unpredictable.   |
The Motley Fool
November 8, 2011
Brian Wilson |
2 Health-Care Stocks for Times of Uncertainty Just because Abbott and Johnson & Johnson don't undertake as much risk as other health-care giants doesn't mean that shareholders won't see impressive growth in revenues. |
The Motley Fool
April 22, 2009
Selena Maranjian |
Will Health-Care Reform Hurt Investors? The bad news here is that there's quite a bit of uncertainty around this issue, and that some health-care-focused companies may end up suffering. Read on to see who. |
The Motley Fool
May 12, 2010
Matt Koppenheffer |
Are Health-Care Stocks a Buy? Health-care stocks have underperformed the market so far this year. Is it time for a turnaround? |
The Motley Fool
August 19, 2010
Brian Orelli |
Buffett Is Buying J&J. Should You? It depends on your time horizon. |
The Motley Fool
January 17, 2012
Brian Orelli |
Pharma Focus Is Good For Your Portfolio Build your own portfolio. |
The Motley Fool
January 25, 2011
Eric Dutram |
Tuesday's ETF to Watch: iShares Dow Jones U.S. Health Care Index Fund (IYH) The health-care sector has stagnated in recent weeks -- what does that mean for these ETFs? |
The Motley Fool
December 9, 2011
Paul Chi |
3 Europe-Proof Stocks for Your Portfolio These health-care stocks are Europe-proof. |
The Motley Fool
January 20, 2010
Brian Orelli |
Health-Care Reform: It's Not Over Yet Massachusetts has spoken with its election of Scott Brown to the Senate. What's up next? |
The Motley Fool
July 17, 2008
Brian Orelli |
Investors Yawn at Abbott Labs' Growth Abbott Labs may be firing on all cylinders, but investors were less than impressed with its earnings release |
The Motley Fool
August 4, 2010
Amanda B. Kish |
3 Big Bets on Health Care As Americans age, funds heavy in health care could really pay off. |
The Motley Fool
November 16, 2009
Amanda B. Kish |
The Hottest Sector for 2010 It's hard to argue that the potential benefits to this sector won't be significant if health care reform does work its way through. The time to stock up on high-quality health-care names is now. |
The Motley Fool
December 3, 2009
Brian Orelli |
Health-Care Reform Is Very Taxing On the industries that keep us alive. |
The Motley Fool
January 28, 2010
Brian Orelli |
Health-Care Reform Is Dead. Probably. Breaking up the bill doesn't seem like the answer. What do insurers and pharmaceutical companies have to say? |
The Motley Fool
September 30, 2009
Dave Mock |
Health-Care Stocks Obama Would Buy This up-and-coming sector could play a big role in reform, especially for companies that bring new efficiencies to health care. |
The Motley Fool
May 12, 2009
Brian Orelli |
Your Company Is Giving Away Revenue Bad news for investors in the health-care industry: the companies you invest in just pledged to give back 1.5% of their expected U.S. revenue growth to President Obama. |
The Motley Fool
November 20, 2009
Kris Eddy |
Drug Companies Targeted, Again Is a review of drug prices by Congress something to worry about? |
The Motley Fool
March 5, 2009
Brian Orelli |
5 Stocks to Benefit From China's Health-Care Plan Same idea, different country. |
The Motley Fool
June 15, 2011
Brian Orelli |
Johnson & Johnson Is a Quitter The diversified health-care giant has decided to exit the drug-eluting stent market. |
The Motley Fool
August 24, 2010
Brian Orelli |
One Day, the J&J Recalls Will End Just not today. Johnson & Johnson's consumer health segment gets more than half of its sales from outside the U.S., so tainting its image outside the U.S. could be costly as well. |
The Motley Fool
December 9, 2009
Brian Orelli |
Welcome to Club Biogeneric, Pfizer! The megadrugmaker jumps on the biogeneric bandwagon. |
The Motley Fool
February 24, 2011
Brian Orelli |
Abbott: 1, Johnson & Johnson: 0 -- For Now Abbott Labs got a ruling overturned yesterday that would have cost the company $1.8 billion, yet investors let shares slip down 1%. |
The Motley Fool
October 5, 2009
Dan Caplinger |
Where the Real Value Is Now Here's a sample of stocks that look relatively cheap compared with their peers and the overall market: Chevron... Oracle... FMC... Raytheon... Kraft Foods... |
The Motley Fool
November 15, 2011
Dan Caplinger |
Has Abbott Labs Become the Perfect Stock? For long-term investors, Abbott's continuing devotion to up its dividend -- its streak now stands at 39 years -- makes a compelling reason to hold onto your shares. |
The Motley Fool
November 22, 2011
Selena Maranjian |
Make Money in Global Health-Care Stocks the Easy Way If you expect the global health-care industry to thrive as our planet's population grows and ages, the iShares S&P Global Health Care ETF could save you a lot of trouble. |
The Motley Fool
January 20, 2009
Brian Orelli |
Johnson & Johnson Nimble ... for Now The health-care giant reports increasing earnings, despite falling revenue. |
The Motley Fool
February 26, 2010
Brian Orelli |
Political Theater: More Entertaining Than Helpful Health-care reform, like health-care stocks, remains still stuck in limbo. |
The Motley Fool
February 24, 2009
Brian Orelli |
Pfizer: Diversified Dreams, Dubious Decisions Pfizer's CEO Jeffrey Kindler said he wants to make his company more like Johnson & Johnson and Abbott Labs, which aren't dependent on one product for success. |
The Motley Fool
September 17, 2009
Charly Travers |
Companies That Will Thrive Under Obamacare They are out there. |
The Motley Fool
April 4, 2011
Selena Maranjian |
This Expense Could Wipe You Out You probably already realize that a significant amount of your spending in retirement will go toward health care. But you may still be surprised when you see the actual average price tag. |
CFO
December 1, 2009
Scott Leibs |
Health Reform CFOs atypically cast their gaze far into the future when it comes to the impact of health-care reform. |
The Motley Fool
August 28, 2009 |
Roundtable: Will Health-Care Reform Kill Capitalism? Motley Fool analysts give their opinions on the health-care reform debate. |
The Motley Fool
February 28, 2011
David Williamson |
Don't Miss These Health-Care ETFs Two ways ETFs can help your portfolio |
The Motley Fool
December 20, 2010
Dan Caplinger |
2 Smart Sectors for 2011 Are beaten-down sector ETFs the best bets? |
The Motley Fool
February 9, 2010
Brian Orelli |
What Bipartisan Health-Care Reform Means for Investors Republicans and Democrats will debate on TV, but little may come of it. |
The Motley Fool
July 14, 2008
Brian Orelli |
Foolish Forecast: J&J Trudges Along In advance of earnings analysts wonder if Johnson & Johnson is a recovery story waiting to happen, or still stuck in a rut? |
The Motley Fool
September 3, 2009
Brian Orelli |
Now That's How to Grow a Company! Dear Pfizer and Merck, you really should take note of how Abbott Labs is growing. |
The Motley Fool
July 31, 2009
Brian Orelli |
A Health-Care Investor's Nightmare When it comes to health-care reform, no news is not good news; the House's recent plan to delay voting on a health-care reform bill until September should have investors reaching for the antacids. |
The Motley Fool
March 24, 2009
Robert Steyer |
Drugmakers Diversify -- Again Merck and Pfizer choose businesses they once eschewed. |
The Motley Fool
June 22, 2010 |
UnitedHealth and Wellpoint: Looking Good for the Long Term There are two big players -- UnitedHealth Group and WellPoint -- that are still trading at historical lows. |
The Motley Fool
June 14, 2011
Selena Maranjian |
Make Money in Health Care the Easy Way There's no need to guess which health-care company will perform best when you invest in the Vanguard Health Care ETF. |
The Motley Fool
July 20, 2010
Brian Orelli |
Is J&J a Bad News Buy? Another quarter in 2010, another lowered earnings guidance for Johnson & Johnson. At least the year is half over for the health-care giant. |
The Motley Fool
October 31, 2009
Shannon Zimmerman |
Obamacare PASS! The One Stock to Buy Real reform will create real opportunity in health insurance and medical industry stocks |
The Motley Fool
September 28, 2009
Brian Orelli |
The Berkshire of Health Care Johnson & Johnson is becoming the Berkshire Hathaway of health care. In addition to its usual M.O. of bolt-on acquisitions, the health-care giant has recently taken some equity stakes in smaller drug companies. |
The Motley Fool
October 13, 2008
Brian Orelli |
Foolish Forecast: J&J's Diversity Counts Views you can use to get clues on tomorrow's news |
The Motley Fool
December 18, 2009
Brian Orelli |
2009: The Year Pharma Learned to Love Itself While anything is possible, don't expect too much more consolidation of major drugmakers in 2010 and beyond. |
The Motley Fool
June 30, 2009
Brian Orelli |
Johnson & Johnson Inflames Abbott $1.67 billion is one hefty reward. |
The Motley Fool
October 30, 2009
Brian Orelli |
Come On -- They Represent Your Mom! A Republican fight with AARP proves that we're still seeing politics as usual. |
The Motley Fool
May 22, 2009
Brian Orelli |
J&J and Cougar: Meow or Roar? Health-care giant Johnson & Johnson is doing something that many of its investors -- Buffett included -- wouldn't do; it's buying a development-stage drugmaker that has no proven drugs. |
The Motley Fool
August 27, 2010
Brian Orelli |
A Recall a Week, That's All We Ask For Johnson & Johnson, apparently that's too much. |
